NCT01772264View on ClinicalTrials.gov

Safety And Tolerability Study Of BID Titration Scheme With PF-05089771

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Healthy
Interventions
DRUG

PF-05089771

titration from 150mg BID to 450mg BID

DRUG

Placebo

matched placebo

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01772264 - Safety And Tolerability Study Of BID Titration Scheme With PF-05089771 | Biotech Hunter | Biotech Hunter